Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Promise of Molecular Medicine

Philip Seo, MD, MHS  |  Issue: September 2018  |  September 19, 2018

Seeing a large number of patients with systemic vasculitis, I have come to anticipate the questions that patients will kick themselves for not having asked. In French, they talk about l’esprit d’escalier—the witty remark that comes to mind as you are on the staircase, taking your exit from the party. I guess this is more like l’esprit de voiture—the comment or the question that comes to mind only when the patient dissects their clinic visit with me on the long car ride home.

One of the unasked questions I try to answer in advance is the risk that might be conferred to one’s children. In the modified Kübler-Ross stages of coming to terms with a chronic illness, the step right before acceptance is guilt—either over what the patient did to give themself this diagnosis or whether the sins of the father might truly be visited upon the children.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

With regard to the former, I spend a large amount of time reassuring patients that I have heard it all: I just got married. I just got divorced. I just moved from California. My mother just passed. I think my house might have toxic mold. Everyone has a theory about why they developed systemic vasculitis, and like snowflakes, each one is unique and ephemeral. Some exposures have been linked to an increased risk of developing certain types of vasculitis, but in general, my patients haven’t read those papers and cite more workaday concerns. In general, I tell them that even if they are correct, and it was the exposure to dirty pool water that started their descent, that bell can’t be unrung.

I find that patients breathe the biggest sigh of relief when I tell them that close relatives—children, grandchildren—are generally not at higher risk of developing a systemic vasculitis, and I wouldn’t recommend any special screening or avoidance of certain foods or treating them with kid gloves in any way.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I say this largely based on a study that used the Swedish national registries to identify almost 2,000 Swedish patients with granulomatosis with polyangiitis (GPA) and their 6,670 first-degree relatives and 428 spouses. Only 0.02% of the first-degree relatives (and 0% of the spouses) also had GPA.1 Although this doesn’t necessarily prove the case for all forms of vasculitis, until I see data to the contrary, I tell my patients not to worry. Unless, of course, they have an older brother who tortured them when they were a kid. In which case, what’s the point of having a rare disease if you can’t have a little fun with it from time to time?

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:Genesgenetics

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

    Experts Discuss the Latest Precision Medicine Research

    February 18, 2018

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences